{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:55:18Z","timestamp":1786982118613,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,11,25]],"date-time":"2008-11-25T00:00:00Z","timestamp":1227571200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Diab Rep"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s11892-008-0081-3","type":"journal-article","created":{"date-parts":[[2008,11,26]],"date-time":"2008-11-26T10:45:27Z","timestamp":1227696327000},"page":"470-476","source":"Crossref","is-referenced-by-count":46,"title":["Vascular endothelial growth factor and diabetic nephropathy"],"prefix":"10.1007","volume":"8","author":[{"given":"Sheldon","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuad N.","family":"Ziyadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,11,25]]},"reference":[{"key":"81_CR1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/157339908783502370","volume":"4","author":"F.N. Ziyadeh","year":"2008","unstructured":"Ziyadeh FN, Wolf G: Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Curr Diabetes Rev 2008, 4:39\u201345.","journal-title":"Curr Diabetes Rev"},{"key":"81_CR2","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1126\/science.6823562","volume":"219","author":"D.R. Senger","year":"1983","unstructured":"Senger DR, Galli SJ, Dvorak AM, et al.: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983, 219:983\u2013985.","journal-title":"Science"},{"key":"81_CR3","doi-asserted-by":"crossref","first-page":"F1665","DOI":"10.1152\/ajprenal.00495.2006","volume":"292","author":"T. Nakagawa","year":"2007","unstructured":"Nakagawa T: Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease. Am J Physiol Renal Physiol 2007, 292:F1665\u2013F1672.","journal-title":"Am J Physiol Renal Physiol"},{"key":"81_CR4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nature03987","volume":"437","author":"S.M. Weis","year":"2005","unstructured":"Weis SM, Cheresh DA: Pathophysiological consequences of VEGF-induced vascular permeability. Nature 2005, 437:497\u2013504.","journal-title":"Nature"},{"key":"81_CR5","doi-asserted-by":"crossref","first-page":"F1657","DOI":"10.1152\/ajprenal.00274.2007","volume":"293","author":"A. Wang","year":"2007","unstructured":"Wang A, Ziyadeh FN, Lee EY, et al.: Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria. Am J Physiol Renal Physiol 2007, 293:F1657\u2013F1665.","journal-title":"Am J Physiol Renal Physiol"},{"key":"81_CR6","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.2337\/diabetes.54.10.2891","volume":"54","author":"K. Ichinose","year":"2005","unstructured":"Ichinose K, Maeshima Y, Yamamoto Y, et al.: Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model. Diabetes 2005, 54:2891\u20132903.","journal-title":"Diabetes"},{"key":"81_CR7","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2337\/diabetes.53.7.1831","volume":"53","author":"Y. Yamamoto","year":"2004","unstructured":"Yamamoto Y, Maeshima Y, Kitayama H, et al.: Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy. Diabetes 2004, 53:1831\u20131840.","journal-title":"Diabetes"},{"key":"81_CR8","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.2337\/diabetes.48.11.2229","volume":"48","author":"M.E. Cooper","year":"1999","unstructured":"Cooper ME, Vranes D, Youssef S, et al.: Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes 1999, 48:2229\u20132239.","journal-title":"Diabetes"},{"key":"81_CR9","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/labinvest.3700082","volume":"84","author":"A.K. Singh","year":"2004","unstructured":"Singh AK, Gudehithlu KP, Pegoraro AA, et al.: Vascular factors altered in glucose-treated mesangial cells and diabetic glomeruli. Changes in vascular factors impair endothelial cell growth and matrix. Lab Invest 2004, 84:597\u2013606.","journal-title":"Lab Invest"},{"key":"81_CR10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/emm.2004.9","volume":"36","author":"E.Y. Lee","year":"2004","unstructured":"Lee EY, Shim MS, Kim MJ, et al.: Angiotensin II receptor blocker attenuates overexpression of vascular endothelial growth factor in diabetic podocytes. Exp Mol Med 2004, 36:65\u201370.","journal-title":"Exp Mol Med"},{"key":"81_CR11","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1681\/ASN.2006010064","volume":"17","author":"S.H. Sung","year":"2006","unstructured":"Sung SH, Ziyadeh FN, Wang A, et al.: Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice. J Am Soc Nephrol 2006, 17:3093\u20133104.","journal-title":"J Am Soc Nephrol"},{"key":"81_CR12","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.2337\/diabetes.54.8.2328","volume":"54","author":"Z. Wang","year":"2005","unstructured":"Wang Z, Jiang T, Li J, et al.: Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb\/db mice with type 2 diabetes. Diabetes 2005, 54:2328\u20132335.","journal-title":"Diabetes"},{"key":"81_CR13","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s001250051198","volume":"42","author":"K. Tsuchida","year":"1999","unstructured":"Tsuchida K, Makita Z, Yamagishi S, et al.: Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195. Diabetologia 1999, 42:579\u2013588.","journal-title":"Diabetologia"},{"key":"81_CR14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1677\/joe.1.05647","volume":"183","author":"D.R. Cha","year":"2004","unstructured":"Cha DR, Kang YS, Han SY, et al.: Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats. J Endocrinol 2004, 183:183\u2013194.","journal-title":"J Endocrinol"},{"key":"81_CR15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/labinvest.3780392","volume":"82","author":"S. Hoshi","year":"2002","unstructured":"Hoshi S, Shu Y, Yoshida F, et al.: Podocyte injury promotes progressive nephropathy in Zucker diabetic fatty rats. Lab Invest 2002, 82:25\u201335.","journal-title":"Lab Invest"},{"key":"81_CR16","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/S0024-3205(01)01327-3","volume":"69","author":"L. Braun","year":"2001","unstructured":"Braun L, Kardon T, Reisz-Porszasz ZS, et al.: The regulation of the induction of vascular endothelial growth factor at the onset of diabetes in spontaneously diabetic rats. Life Sci 2001, 69:2533\u20132542.","journal-title":"Life Sci"},{"key":"81_CR17","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1093\/nar\/gni051","volume":"33","author":"G. Belteki","year":"2005","unstructured":"Belteki G, Haigh J, Kabacs N, et al.: Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline induction. Nucleic Acids Res 2005, 33:e51.","journal-title":"Nucleic Acids Res"},{"key":"81_CR18","unstructured":"Sison K, Fantus IG, Quaggin SE: Podocyte-specific increase in VEGF-A production leads to rapid alterations in glomerular permeability and features of diabetic nephropathy [abstract F-FC193]. Presented at the 38th Annual American Society of Nephrology Meeting. Philadelphia; November 10\u201313, 2005."},{"key":"81_CR19","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1681\/ASN.2006091012","volume":"18","author":"L. Wilkinson","year":"2007","unstructured":"Wilkinson L, Gilbert T, Kinna G, et al.: Crim1KST264\/ KST264 mice implicate Crim1 in the regulation of vascular endothelial growth factor-A activity during glomerular vascular development. J Am Soc Nephrol 2007, 18:1697\u20131708.","journal-title":"J Am Soc Nephrol"},{"key":"81_CR20","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/ndt\/13.4.875","volume":"13","author":"B. Klanke","year":"1998","unstructured":"Klanke B, Simon M, Rockl W, et al.: Effects of vascular endothelial growth factor (VEGF)\/vascular permeability factor (VPF) on haemodynamics and permselectivity of the isolated perfused rat kidney. Nephrol Dial Transplant 1998, 13:875\u2013885.","journal-title":"Nephrol Dial Transplant"},{"key":"81_CR21","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1681\/ASN.V125993","volume":"12","author":"A.S. Vriese De","year":"2001","unstructured":"De Vriese AS, Tilton RG, Elger M, et al.: Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol 2001, 12:993\u20131000.","journal-title":"J Am Soc Nephrol"},{"key":"81_CR22","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.2337\/diabetes.51.10.3090","volume":"51","author":"A. Flyvbjerg","year":"2002","unstructured":"Flyvbjerg A, Dagnaes-Hansen F, De Vriese AS, et al.: Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody. Diabetes 2002, 51:3090\u20133094.","journal-title":"Diabetes"},{"key":"81_CR23","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1681\/ASN.V75661","volume":"7","author":"K. Shulman","year":"1996","unstructured":"Shulman K, Rosen S, Tognazzi K, et al.: Expression of vascular permeability factor (VPF\/VEGF) is altered in many glomerular diseases. J Am Soc Nephrol 1996, 7:661\u2013666.","journal-title":"J Am Soc Nephrol"},{"key":"81_CR24","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/sj.ki.5002101","volume":"71","author":"H.J. Baelde","year":"2007","unstructured":"Baelde HJ, Eikmans M, Lappin DW, et al.: Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss. Kidney Int 2007, 71:637\u2013645.","journal-title":"Kidney Int"},{"key":"81_CR25","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/jcp.52.10.735","volume":"52","author":"E. Bailey","year":"1999","unstructured":"Bailey E, Bottomley MJ, Westwell S, et al.: Vascular endothelial growth factor mRNA expression in minimal change, membranous, and diabetic nephropathy demonstrated by non-isotopic in situ hybridisation. J Clin Pathol 1999, 52:735\u2013738.","journal-title":"J Clin Pathol"},{"key":"81_CR26","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1530\/eje.0.1500799","volume":"150","author":"E. Bortoloso","year":"2004","unstructured":"Bortoloso E, Del Prete D, Dalla Vestra M, et al.: Quantitative and qualitative changes in vascular endothelial growth factor gene expression in glomeruli of patients with type 2 diabetes. Eur J Endocrinol 2004, 150:799\u2013807.","journal-title":"Eur J Endocrinol"},{"key":"81_CR27","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1681\/ASN.2006121304","volume":"18","author":"M.T. Lindenmeyer","year":"2007","unstructured":"Lindenmeyer MT, Kretzler M, Boucherot A, et al.: Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. J Am Soc Nephrol 2007, 18:1765\u20131776.","journal-title":"J Am Soc Nephrol"},{"key":"81_CR28","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1053\/j.ajkd.2004.09.020","volume":"45","author":"Y. Kanesaki","year":"2005","unstructured":"Kanesaki Y, Suzuki D, Uehara G, et al.: Vascular endothelial growth factor gene expression is correlated with glomerular neovascularization in human diabetic nephropathy. Am J Kidney Dis 2005, 45:288\u2013294.","journal-title":"Am J Kidney Dis"},{"key":"81_CR29","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/147323000703500312","volume":"35","author":"D. Janickova Zdarska","year":"2007","unstructured":"Janickova Zdarska D, Zavadova E, Kvapil M: The effect of ramipril therapy on cytokines and parameters of incipient diabetic nephropathy in patients with type 1 diabetes mellitus. J Int Med Res 2007, 35:374\u2013383.","journal-title":"J Int Med Res"},{"key":"81_CR30","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/sj.ki.5000294","volume":"69","author":"B. Hohenstein","year":"2006","unstructured":"Hohenstein B, Hausknecht B, Boehmer K, et al.: Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man. Kidney Int 2006, 69:1654\u20131661.","journal-title":"Kidney Int"},{"key":"81_CR31","first-page":"90","volume":"17","author":"R. Cipriani","year":"2004","unstructured":"Cipriani R, Sensi M, Gabriele A, et al.: The impairment of renal function is not associated to altered circulating vascular endothelial growth factor in patients with type 2 diabetes and hypertension. Diabetes Nutr Metab 2004, 17:90\u201394.","journal-title":"Diabetes Nutr Metab"},{"key":"81_CR32","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1464-5491.2004.01094.x","volume":"21","author":"T. Baba","year":"2004","unstructured":"Baba T, Osterby R, Neugebauer-Baba S, et al.: No nephropathy in type 2 diabetic patient with POEMS syndrome with an elevated plasma VEGF. Diabet Med 2004, 21:292\u2013294.","journal-title":"Diabet Med"},{"key":"81_CR33","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1046\/j.1523-1755.2000.00094.x","volume":"57","author":"E.O. Honkanen","year":"2000","unstructured":"Honkanen EO, Teppo AM, Gronhagen-Riska C: Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis. Kidney Int 2000, 57:2343\u20132349.","journal-title":"Kidney Int"},{"key":"81_CR34","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1159\/000073940","volume":"26","author":"T. Lenz","year":"2003","unstructured":"Lenz T, Haak T, Malek J, et al.: Vascular endothelial growth factor in diabetic nephropathy. Kidney Blood Press Res 2003, 26:338\u2013343.","journal-title":"Kidney Blood Press Res"},{"key":"81_CR35","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S1056-8727(02)00162-9","volume":"16","author":"K. Shimada","year":"2002","unstructured":"Shimada K, Baba T, Neugebauer S, et al.: Plasma vascular endothelial growth factor in Japanese type 2 diabetic patients with and without nephropathy. J Diabetes Complications 2002, 16:386\u2013390.","journal-title":"J Diabetes Complications"},{"key":"81_CR36","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1046\/j.1523-1755.2000.07504.x","volume":"75","author":"P. Hovind","year":"2000","unstructured":"Hovind P, Tarnow L, Oestergaard PB, Parving HH: Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy. Kidney Int Suppl 2000, 75:S56\u2013S61.","journal-title":"Kidney Int Suppl"},{"key":"81_CR37","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1046\/j.1464-5491.2000.00350.x","volume":"17","author":"F. Chiarelli","year":"2000","unstructured":"Chiarelli F, Spagnoli A, Basciani F, et al.: Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with type 1 diabetes mellitus: relation to glycaemic control and microvascular complications. Diabet Med 2000, 17:650\u2013656.","journal-title":"Diabet Med"},{"key":"81_CR38","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/jcem.86.8.7752","volume":"86","author":"F. Santilli","year":"2001","unstructured":"Santilli F, Spagnoli A, Mohn A, et al.: Increased vascular endothelial growth factor serum concentrations may help to identify patients with onset of type 1 diabetes during childhood at risk for developing persistent microalbuminuria. J Clin Endocrinol Metab 2001, 86:3871\u20133876.","journal-title":"J Clin Endocrinol Metab"},{"key":"81_CR39","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1464-5491.2004.01200.x","volume":"21","author":"N.H. Kim","year":"2004","unstructured":"Kim NH, Kim KB, Kim DL, et al.: Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in type 2 diabetes mellitus. Diabet Med 2004, 21:545\u2013551.","journal-title":"Diabet Med"},{"key":"81_CR40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1523-1755.2005.00067.x","volume":"67","author":"N.H. Kim","year":"2005","unstructured":"Kim NH, Oh JH, Seo JA, et al.: Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy. Kidney Int 2005, 67:167\u2013177.","journal-title":"Kidney Int"},{"key":"81_CR41","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2337\/diabetes.53.3.861","volume":"53","author":"D. Ray","year":"2004","unstructured":"Ray D, Mishra M, Ralph S, et al.: Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes. Diabetes 2004, 53:861\u2013864.","journal-title":"Diabetes"},{"key":"81_CR42","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/j.ajkd.2003.12.028","volume":"43","author":"H.J. Baelde","year":"2004","unstructured":"Baelde HJ, Eikmans M, Doran PP, et al.: Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy. Am J Kidney Dis 2004, 43:636\u2013650.","journal-title":"Am J Kidney Dis"},{"key":"81_CR43","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ndt\/gfl641","volume":"22","author":"M. Buraczynska","year":"2007","unstructured":"Buraczynska M, Ksiazek P, Baranowicz-Gaszczyk I, Jozwiak L: Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetes patients. Nephrol Dial Transplant 2007, 22:827\u2013832.","journal-title":"Nephrol Dial Transplant"},{"key":"81_CR44","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.2337\/db07-0376","volume":"56","author":"H. Al-Kateb","year":"2007","unstructured":"Al-Kateb H, Mirea L, Xie X, et al.: Multiple variants in vascular endothelial growth factor (VEGFA) are risk factors for time to severe retinopathy in type 1 diabetes: the DCCT\/EDIC genetics study. Diabetes 2007, 56:2161\u20132168.","journal-title":"Diabetes"},{"key":"81_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1056-8727(02)00181-2","volume":"17","author":"B. Yang","year":"2003","unstructured":"Yang B, Cross DF, Ollerenshaw M, et al.: Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus. J Diabetes Complications 2003, 17:1\u20136.","journal-title":"J Diabetes Complications"},{"key":"81_CR46","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jdiacomp.2006.05.005","volume":"21","author":"A.J. McKnight","year":"2007","unstructured":"McKnight AJ, Maxwell AP, Patterson CC, et al.: Association of VEGF-1499C\u2192T polymorphism with diabetic nephropathy in type 1 diabetes mellitus. J Diabetes Complications 2007, 21:242\u2013245.","journal-title":"J Diabetes Complications"},{"key":"81_CR47","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1096\/fj.05-4240fje","volume":"19","author":"L. Zeng","year":"2005","unstructured":"Zeng L, Xu H, Chew TL, et al.: HMG CoA reductase inhibition modulates VEGF-induced endothelial cell hyper-permeability by preventing RhoA activation and myosin regulatory light chain phosphorylation. FASEB J 2005, 19:1845\u20131847.","journal-title":"FASEB J"},{"key":"81_CR48","doi-asserted-by":"crossref","first-page":"p32","DOI":"10.1159\/000101798","volume":"106","author":"V. Eremina","year":"2007","unstructured":"Eremina V, Baelde HJ, Quaggin SE: Role of the VEGF-A signaling pathway in the glomerulus: evidence for crosstalk between components of the glomerular filtration barrier. Nephron Physiol 2007, 106:p32\u2013p37.","journal-title":"Nephron Physiol"},{"key":"81_CR49","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.2337\/diabetes.53.11.2939","volume":"53","author":"S. Chen","year":"2004","unstructured":"Chen S, Kasama Y, Lee JS, et al.: Podocyte-derived vascular endothelial growth factor mediates the stimulation of alpha3(IV) collagen production by transforming growth factor-beta1 in mouse podocytes. Diabetes 2004, 53:2939\u20132949.","journal-title":"Diabetes"},{"key":"81_CR50","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.2337\/db05-1367","volume":"55","author":"K. Ichinose","year":"2006","unstructured":"Ichinose K, Maeshima Y, Yamamoto Y, et al.: 2-(8-hydroxy-6-methoxy-1-oxo-1h-2-benzopyran-3-yl) propionic acid, an inhibitor of angiogenesis, ameliorates renal alterations in obese type 2 diabetic mice. Diabetes 2006, 55:1232\u20131242.","journal-title":"Diabetes"}],"container-title":["Current Diabetes Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-008-0081-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11892-008-0081-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-008-0081-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T04:11:32Z","timestamp":1632370292000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11892-008-0081-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,25]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["81"],"URL":"https:\/\/doi.org\/10.1007\/s11892-008-0081-3","relation":{},"ISSN":["1534-4827","1539-0829"],"issn-type":[{"value":"1534-4827","type":"print"},{"value":"1539-0829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,25]]}}}